Document is current
Any future updates will be listed below
-
Authors
Pannu, Sukhmani
Rosmarin, David
- License Information
-
More Information
Article History
Accepted: 23 January 2021
First Online: 15 February 2021
Declarations
:
: No sources of funding were used to conduct this study or prepare this manuscript.
: Sukhmani Pannu has received a fellowship research grant from AbbVie pharmaceuticals. David Rosmarin has received honoraria as a consultant for AbbVie, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Concert, Dermavant, Dermira, Incyte, Janssen, Kyowa Kirin, Lilly, Novartis, Pfizer, Regeneron, Sanofi, Sun Pharmaceuticals, UCB, and Viela Bio; has received research support from AbbVie, Amgen, Bristol Myers Squibb, Celgene, Dermira, Galderma, Incyte, Janssen, Lilly, Merck, Novartis, Pfizer, and Regeneron Pharmaceuticals Inc.; and has served as a paid speaker for AbbVie, Amgen, Celgene, Janssen, Lilly, Novartis, Pfizer, Regeneron Pharmaceuticals Inc., and Sanofi.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: SP: writing and data collection from literature. DR: design, writing and revising.
